Browse drugs

…cranial samples were 57% (16/28) with 22C3 and 61% (17/28) with SP263. For 24 patients receiving intrathecal immunotherapy, the corre…

…112-pixels) to train a vision transformer model (ViT-B/16)6 for PD-L1 binary classification (figure 1).Results Our Pix2Pix GAN model …

…itic cells with costimulatory molecule expression.Conclusions A PD-L1xVδ2 bsTCE was generated that acts as PD-1/PD-L1 immune checkpoint inhibit…

…r (chr20:25849353-25849490) improves response prediction beyond PD-L1 CPS and represents a potential predictive biomarker for combina…

…ts with PD-L1/PD-L2 co-amplification.In the patients, receiving anti PD-1, patients with PD-L1/PD-L2 co-amplification had higher OS compa…

… during treatment with PD-1 inhibitors. Eight patients received pembrolizumab (six as monotherapy and two in combination with carboplatin plu…

…e dual-payload ADC with immune checkpoint inhibitors (PD-L1 and 4–1BB) not only rapidly bridges innate and adaptive immunity but also…

…Background Neoadjuvant PD-1/PD-L1 blockade yields robust efficacy in advanced cutaneous squamous …

…ients: (1) patients with advanced cancer treated with anti-PD-1/PD-L1 alone and (2) patients with advanced non-small cell lung cancer…

…ith filters for RCTs. We restricted our analysis to ipilimumab, nivolumab, pembrolizumab, atezolizumab, avelumab, durvalumab, cemiplimab …

…estigational. These include immune checkpoint inhibitors (PD-1, PD-L1, OX40), bispecific T engagers (CD3xCD20 or CD3xEGFR), and tumor…